Barrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $96
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an 'Outperform' rating on Merit Medical Systems (NASDAQ:MMSI) and raised the price target from $95 to $96.
October 27, 2023 | 2:28 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems' price target has been raised from $95 to $96 by Barrington Research, which maintains an 'Outperform' rating on the stock.
The raised price target and 'Outperform' rating by Barrington Research indicates a positive outlook for Merit Medical Systems. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100